Research projects
Current research projects:
finalised:
Marie Curie Initial Training Networks (ITN): “BIOART”
Training network for developing innovative (bio)artificial devices for treatment of kidney and liver disease
EINHORN: Innovative hollow fibre membranes for next generation wound healing management
Investigation of an impedance spectrometric method for monitoring cell growth/
protein cell occupancy in hollow fibre bioreactors/dialysers
NPORE: Development, characterisation and validation of nanoparticles for adsorption of hydrophobic uremic toxins in renal failure patients
NanoCare: Silver nanoparticles – mode of action and research into their possible interaction with tissues, cells and molecules. Definition of their relevant biocompatibility potential.
MOST: Development of membranes showing improved characteristics in chronic hemodialysis and improved lifetime in intensive medical care (acute hemodialysis)
Artificial Artery: Aim of the project is, to develop an „artificial artery” as a hemodynamically stimulated co-culture model which could be an alternative to animal testing. One possible target will be industrial testing in the area of cardio-vascular diseases.
NT-CVD: Development and validation of new diagnostic, preventive and therapeutic measures to prevent cardio-vascular dysfunction in chronic renal disease
Establishment of a clinical procedure to remove protein bound toxins from plasma
Eid: Development of a method to control cell growth and protein/cell layers in hollow fiber bioreactors by impedance spectroscopy
MÖBIUS: Development of a multiadaptive micro-opto-electronic bragg sensor system for fluid analysis (“lab on a chip”)
To ensure that our tests meet the requirements of our customers, we have established a quality system that fulfils all the requirements of DIN EN ISO/IEC 17025:2018 and ensures the implementation of our quality policy. This makes us an accredited testing and research institute in the areas mentioned. Our accreditation is valid in around 46 countries worldwide (including the EU, the USA and Japan), as a mutual recognition agreement, known as the ILAC Arrangement, applies between the laboratory accreditation bodies of these countries.
